Nextgen Bioscience is a company that operates in the Biotechnology industry. It employs 21-50 people and has $5M-$10M of revenue. The company is headquartered in Korea, Republic of.
| Website | http://www.nextgenbio.co.kr |
| Revenue | $5.1 million |
| Employees | 3 (2 on RocketReach) |
| Industry | Manufacturing General, Manufacturing |
| Keywords | Immunology, Biotechnology, Biomanufacturing, Biopharmaceutical, Genetic Engineering, Biotechnology Research, Pharmaceutical Research, Drug Discovery, Biomedical Research, Molecular Biology, Cell Biology, Biotechnology Solutions, Bioscience Research, Genetic Research, Pharmaceutical Development, Biologics, Clinical Trials, Therapeutics, Bioprocessing |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, BD, Illumina, PacBio, 10x Genomics, QIAGEN, Celerion, Stilla Technologies +38 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Nextgen Bioscience employee's phone or email?
The Nextgen Bioscience annual revenue was $5.1 million in 2026.
Bongyong Lee is the CEO of Nextgen Bioscience.
2 people are employed at Nextgen Bioscience.
The NAICS codes for Nextgen Bioscience are [325, 3254, 32].
The SIC codes for Nextgen Bioscience are [28, 80, 283].